Roivant Sciences (ROIV) Minority Interest (2021 - 2026)

Roivant Sciences (ROIV) has reported Minority Interest for 6 consecutive years, with $690.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Minority Interest rose 46.85% year-over-year to $690.6 million; the trailing twelve-month figure through Jun 2026 stood at $690.6 million (up 46.85% YoY), and the FY2026 full-year result was $765.0 million, up 53.13% from the prior year.
• Minority Interest eased to $690.6 million in Q2 2026 per ROIV's latest filing, from $765.0 million in the prior quarter.
• Across five years, Minority Interest topped out at $765.0 million in Q1 2026 and bottomed at $346.5 million in Q4 2024.
• Historically, Minority Interest has averaged $478.4 million across 5 years, with a median of $454.9 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Minority Interest fell 29.97% in 2024, then surged 103.46% in 2025.
• Over 5 years, Minority Interest stood at $471.6 million in 2022, then advanced by 4.92% to $494.8 million in 2023, then dropped by 29.97% to $346.5 million in 2024, then soared by 103.46% to $705.0 million in 2025, then slipped by 2.04% to $690.6 million in 2026.
• According to Business Quant data, Minority Interest over the past three periods registered $690.6 million, $765.0 million, and $705.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.